The aim of this study is to examine whether the ACE-I/D, AGT-M235T, and AT1R-A1166C polymorphisms of the renin-angiotensin system (RAS) genes are associated with cardiovascular and renal-related risk factors in Mexican Americans. Study participants (N = 848) were genotyped by Taqman assays. Association analyses were performed by measured genotype approach. Of the phenotypes examined, the ACE-I/D, AGT-M235T, and AT1R-A1166C polymorphisms exhibited signiWcant association with systolic blood pressure, glomerular Wltration rate and body mass index, respectively. The data suggest that the polymorphisms examined in the RAS may modulate the risk factors associated with cardiovascular-renal disease.
The renin-angiotensin system (RAS) plays a central role in the regulation of sodium metabolism, vascular tone, blood pressure, renal haemodynamics, and vascular modelling. Genetic variants of its major components such as the insertion/deletion polymorphisms of angiotensin converting enzyme I (ACE-I/D), the M235T variant of angiotensinogen (AGT-M235T), and the A1166C polymorphism of angiotensin II type 1 receptor (AT1R-A1166C) genes have been implicated in the pathogenesis of hypertension, cardiovascular and renal diseases (Miller and Scholey 2004) . A large number of association studies of cardiovascularrenal-related traits and the above mentioned polymorphisms in the RAS have been mostly conducted in Caucasians and Asians. Furthermore, the association studies have yielded conXicting results. Therefore, the objective of this study is to investigate whether these three polymorphisms are associated with sub clinical cardiovascular and renalrelated risk factors in a cohort representing the Mexican American population.
The San Antonio Family Heart Study (SAFHS) family member recruitment and a variety of metabolic, hemodynamic, anthropometric, and demographic data collection procedures from more than 40 extended families were described previously (MacCluer et al. 1999) . Probands for the SAFHS were selected randomly from a census tract in San Antonio of low-income Mexican Americans regardless of preexisting medical conditions. Estimation of glomerular Wltration rate (eGFR) and albumin to creatinine ratio (ACR) have already been described . The quantitative trait values of ACR (ln ACR) and triglycerides (ln TGL) were log transformed and used in the association analyses since their raw data were non-normally distributed. The Institutional Review Board of the University of Texas Health Science Center at San Antonio approved all procedures, and all subjects gave informed consent.
In this study of 848 participants in 21 families, 52, 22 and 14% of the subjects had hypertension, type 2 diabetes, and albuminuria, respectively. Genotyping of AGT-M235T (rs699), and AT1R-A1166C (rs5186) polymorphisms was performed by TaqMan assays (Applied Biosystems, USA). Genotyping of ACE-I/D (rs1799752) polymorphism was performed by PCR as described (Lovati et al. 2001) . The allele and genotype frequencies were checked for mendalian inconsistencies using INFER, the subroutines of the program PEDSYS and are presented in Table 1 . Genotypic data were consistent with the Hardy-Weinberg Equilibrium expectations. Association analysis in our family data was carried out using the measured genotype approach within the variance components analytical framework implemented in SOLAR (Almasy and Blangero 2004) . To guard against potential eVects of hidden population stratiWcation, we also employed the quantitative trait disequilibrium test (QTDT) approach (Abecasis et al. 2000) . This approach permits a formal test of likely population heterogeneity on a marker-speciWc basis (Havill et al. 2005) . Using this test, we found no evidence for such stratiWcation. Additionally, the results of the QTDT analyses were consistent with the more powerful measured genotype analyses.
Of the phenotypes examined for association, ACE-I/D polymorphism exhibited signiWcant association (P = 0.0031) with systolic blood pressure (SBP) after accounting for trait-speciWc covariate eVects ( Table 2 ). The carriers of the D allele had signiWcantly increased SBP values (I = 123.3 § 1.4, ID = 125.8 § 1.2, and D = 128.3 § 1.5, P = 0.003). Our association results are in agreement with several studies, including a Hispanic cohort demonstrating that the D allele is consistently associated with increased SBP values (Bautista et al. 2008) . As can be seen from Table 2 , association analyses also revealed the presence of signiWcant association between the AGT-M235T variant and eGFR (P = 0.025) after accounting for trait speciWc covariates ( Table 2 ). The carriers of the T allele had signiWcantly decreased eGFR values (M = 104.5 § 1.5, MT = 101.4 § 1.3, and T = 98.3 § 2.3, P = 0.025). Our Wnding conWrms earlier report that the T allele is associated with decline in renal function (Fabris et al. 2005) . Of the phenotypes examined, the AT1R-A1166C polymorphism demonstrated signiWcant association with BMI (P = 0.007) after accounting for age, sex, and diabetes.
Although the elucidation of the pathophysiological mechanisms underlying the risk associated with the examined RAS gene polymorphisms is beyond the scope of this study, it is reasonable to assume that genetic variants may inXuence, through diVerent pathways, the activation of the RAS at the systemic levels. Many vascular cells as well as dipocytes express all the components of RAS. Angiotensin II, the major eVector of RAS acts primarily through AT1R. The variants examined in this study including AT1R-A1166C have been associated with increased RAS activity (van Geel et al. 2000) . Activation of the RAS in adipose tissue has been implicated in the regulation of adiposity and overt obesity through its ability to increase fat cell growth and diVerentiation, increase synthesis, uptake and storage of fatty acids and triglycerides (Jones et al. 1997 ). More- over, activation of the RAS in adipose tissue may represent an important link between obesity and hypertension. Consistent with this notion, it is reasonable to predict from our data that the variants of the RAS examined may be associated with activation of the RAS in vascular and adipose tissue and thereby contributed to the altered blood pressure and BMI. The mechanism by which the AGT-M235T polymorphism aVects renal function estimated by GFR remains to be elucidated. The AGT-M235T polymorphism has been associated with increased production of angiotensin II. Angiotensin II regulates renal hemodynamics and tubular transport, stimulates cytokine formation and release (Ibrahim et al. 1997) . Thus, increased production of angiotensin II due to AGT-M235T within nephrons and their vasculature may participate in local renal injury through altering both hemodynamic and non-hemodynamic/trophic actions of angiotensin II and thereby contribute to renal dysfunction.
This study has limitation in that it focused on three variants of the RAS components examined previously and has not attempted comprehensive tagging of all common variation within the RAS. In addition, the GFR estimated by the ModiWcation of Diet in Renal Disease (MDRD) formula has not been validated in Mexican Americans. However, the MDRD equation is commonly used to estimate GFR and have been employed in several genetic studies (Puppala et al. 2007 , Schelling et al. 2008 Freedman et al. 2008) . It is to be noted that while allowing for multiple testing of SNPs preserves the signiWcance of our three best associations, we, however, did not consider corrections for tests across multiple phenotypes since each phenotype can be considered to reXect an unique hypothesis.
In conclusion, the present study adds evidence for the role of RAS gene polymorphisms in modulating the risk factors related to cardiovascular-renal disease in Mexican Americans.
